Rigel Pharmaceuticals (RIGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 37,890 | -111,547 | -132,346 | -74,272 | -37,637 |
| Depreciation Amortization | 1,317 | 1,403 | 1,425 | 1,344 | 1,418 |
| Accounts receivable | N/A | N/A | N/A | 1,104 | -54 |
| Accounts payable and accrued liabilities | -1,751 | -2,830 | 1,721 | 2,363 | -540 |
| Other Working Capital | -8,900 | -6,073 | 3,644 | 9,034 | -12,196 |
| Other Operating Activity | 18,187 | 16,268 | 22,038 | 8,220 | 13,173 |
| Operating Cash Flow | $46,743 | $-102,779 | $-103,518 | $-52,207 | $-35,836 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -49,843 | -30,537 | -24,481 | -6,864 | 4,778 |
| PPE Investments | -3,560 | -127 | -2,489 | -929 | -830 |
| Investing Cash Flow | $-53,403 | $-30,664 | $-26,970 | $-7,793 | $3,948 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 2,862 | 918 | 1,449 |
| Debt Repayment | -1,144 | -1,448 | -1,244 | -1,495 | -1,406 |
| Common Stock Issued | 1,964 | 103,603 | 130,372 | 57,353 | 2,793 |
| Financing Cash Flow | $820 | $102,155 | $131,990 | $56,776 | $2,836 |
| Beginning Cash Position | 14,717 | 46,005 | 44,503 | 47,727 | 76,779 |
| End Cash Position | 8,877 | 14,717 | 46,005 | 44,503 | 47,727 |
| Net Cash Flow | $-5,840 | $-31,288 | $1,502 | $-3,224 | $-29,052 |
| Free Cash Flow | |||||
| Operating Cash Flow | 46,743 | -102,779 | -103,518 | -52,207 | -35,836 |
| Capital Expenditure | -3,560 | -141 | -2,507 | -933 | -913 |
| Free Cash Flow | 43,183 | -102,920 | -106,025 | -53,140 | -36,749 |